The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...
People with HIV are at increased risk of being reinfected with the virus that causes COVID-19, according to new federal data. Researchers from the Centers for Disease Control and Prevention and the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results